IGM Biosciences is developing antibodies that are different from most monoclonal antibodies currently in use. They have two main pipeline projects focused on cancer and rheumatologic disease. The ...
MOUNTAIN VIEW, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today ...
Technology stocks have performed well in 2023, but there may be more volatility ahead. The iShares Expanded Tech Sector ETF has had a strong rally in 2023, but its valuation is high. The Federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results